Indian drugmaker Zydus Lifesciences' (ZYDU.NS) first-quarter profit dropped by nearly a third, the company reported on Tuesday, as soaring costs offset strong sales in its key markets.
The company's consolidated net profit fell to 9.40 billion rupees ($98.5 million) for the quarter ended June 30, compared with 14.67 billion rupees a year ago.
Here are some more details:
($1 = 95.4300 Indian rupees)
